These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30893303)

  • 21. The human disease network in terms of dysfunctional regulatory mechanisms.
    Yang J; Wu SJ; Dai WT; Li YX; Li YY
    Biol Direct; 2015 Oct; 10():60. PubMed ID: 26450611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression profiling of epithelial ovarian cancer reveals key genes and pathways associated with chemotherapy resistance.
    Zhang M; Luo SC
    Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of potential drugs for diffuse large b-cell lymphoma based on bioinformatics and Connectivity Map database.
    Luo B; Gu YY; Wang XD; Chen G; Peng ZG
    Pathol Res Pract; 2018 Nov; 214(11):1854-1867. PubMed ID: 30244948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ESEA: Discovering the Dysregulated Pathways based on Edge Set Enrichment Analysis.
    Han J; Shi X; Zhang Y; Xu Y; Jiang Y; Zhang C; Feng L; Yang H; Shang D; Sun Z; Su F; Li C; Li X
    Sci Rep; 2015 Aug; 5():13044. PubMed ID: 26267116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
    Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
    Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Network-based biomarkers enhance classical approaches to prognostic gene expression signatures.
    Barter RL; Schramm SJ; Mann GJ; Yang YH
    BMC Syst Biol; 2014; 8 Suppl 4(Suppl 4):S5. PubMed ID: 25521200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Path2enet: generation of human pathway-derived networks in an expression specific context.
    Droste C; De Las Rivas J
    BMC Genomics; 2016 Oct; 17(Suppl 8):731. PubMed ID: 27801297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The potential regulatory mechanisms of the gonadotropin-releasing hormone in gonadotropin transcriptions identified with bioinformatics analyses.
    Xiang W; Zhang B; Lv F; Feng G; Chen L; Yang F; Zhang K; Cao C; Wang P; Chu M
    Reprod Biol Endocrinol; 2017 Jun; 15(1):46. PubMed ID: 28623929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virtual pathway explorer (viPEr) and pathway enrichment analysis tool (PEANuT): creating and analyzing focus networks to identify cross-talk between molecules and pathways.
    Garmhausen M; Hofmann F; Senderov V; Thomas M; Kandel BA; Habermann BH
    BMC Genomics; 2015 Oct; 16():790. PubMed ID: 26467653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urothelial cancer gene regulatory networks inferred from large-scale RNAseq, Bead and Oligo gene expression data.
    de Matos Simoes R; Dalleau S; Williamson KE; Emmert-Streib F
    BMC Syst Biol; 2015 May; 9():21. PubMed ID: 25971253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of hub subnetwork based on topological features of genes in breast cancer.
    Zhuang DY; Jiang L; He QQ; Zhou P; Yue T
    Int J Mol Med; 2015 Mar; 35(3):664-74. PubMed ID: 25573623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated weighted gene co-expression network analysis with an application to chronic fatigue syndrome.
    Presson AP; Sobel EM; Papp JC; Suarez CJ; Whistler T; Rajeevan MS; Vernon SD; Horvath S
    BMC Syst Biol; 2008 Nov; 2():95. PubMed ID: 18986552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adaptive NetworkProfiler for Identifying Cancer Characteristic-Specific Gene Regulatory Networks.
    Park H; Shimamura T; Imoto S; Miyano S
    J Comput Biol; 2018 Feb; 25(2):130-145. PubMed ID: 29053381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of disease-gene-drug relationships following a differential network analysis.
    Zickenrott S; Angarica VE; Upadhyaya BB; del Sol A
    Cell Death Dis; 2016 Jan; 7(1):e2040. PubMed ID: 26775695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
    Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
    BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular concepts analysis links tumors, pathways, mechanisms, and drugs.
    Rhodes DR; Kalyana-Sundaram S; Tomlins SA; Mahavisno V; Kasper N; Varambally R; Barrette TR; Ghosh D; Varambally S; Chinnaiyan AM
    Neoplasia; 2007 May; 9(5):443-54. PubMed ID: 17534450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of regulatory modules in genome scale transcription regulatory networks.
    Song Q; Grene R; Heath LS; Li S
    BMC Syst Biol; 2017 Dec; 11(1):140. PubMed ID: 29246163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.